Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.

Shaw GL, Thomas BC, Dawson SN, Srivastava G, Vowler SL, Gnanapragasam VJ, Shah NC, Warren AY, Neal DE.

Br J Cancer. 2014 May 13;110(10):2405-11. doi: 10.1038/bjc.2014.192. Epub 2014 Apr 10.

2.

Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocols.

Iremashvili V, Pelaez L, Manoharan M, Jorda M, Rosenberg DL, Soloway MS.

Eur Urol. 2012 Sep;62(3):462-8. doi: 10.1016/j.eururo.2012.03.011. Epub 2012 Mar 17.

PMID:
22445138
3.

Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam.

Carlsson S, Maschino A, Schröder F, Bangma C, Steyerberg EW, van der Kwast T, van Leenders G, Vickers A, Lilja H, Roobol MJ.

Eur Urol. 2013 Nov;64(5):693-9. doi: 10.1016/j.eururo.2013.04.040. Epub 2013 May 2.

4.

Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database.

Freedland SJ, Aronson WJ, Csathy GS, Kane CJ, Amling CL, Presti JC Jr, Dorey F, Terris MK; SEARCH Database Study Group.

Urology. 2003 Apr;61(4):742-7.

PMID:
12670558
5.

Minute focus of prostate cancer on needle biopsy: correlation with radical prostatectomy specimen.

Montanari E, Del Nero A, Gazzano G, Mangiarotti B, Bernardini P, Longo F, Cordima G, Itri E.

Arch Ital Urol Androl. 2009 Mar;81(1):9-12.

PMID:
19499751
6.

The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.

Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL.

BJU Int. 2012 Jul;110(1):36-42. doi: 10.1111/j.1464-410X.2011.10681.x. Epub 2011 Nov 15.

7.
8.
9.

Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.

Gallina A, Maccagnano C, Suardi N, Capitanio U, Abdollah F, Raber M, Salonia A, Scattoni V, Rigatti P, Montorsi F, Briganti A.

BJU Int. 2012 Jul;110(2 Pt 2):E64-8. doi: 10.1111/j.1464-410X.2011.10762.x. Epub 2011 Nov 17.

10.

Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?

Jin BS, Kang SH, Kim DY, Oh HG, Kim CI, Moon GH, Kwon TG, Park JS.

Korean J Urol. 2015 Sep;56(9):624-9. doi: 10.4111/kju.2015.56.9.624. Epub 2015 Sep 2.

11.

Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance.

Hong SK, Sternberg IA, Keren Paz GE, Kim PH, Touijer KA, Scardino PT, Eastham JA.

Eur Urol. 2014 Aug;66(2):214-9. doi: 10.1016/j.eururo.2013.08.001. Epub 2013 Aug 11.

PMID:
23954083
13.

Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.

Poulakis V, Witzsch U, de Vries R, Emmerlich V, Meves M, Altmannsberger HM, Becht E.

Urology. 2004 Sep;64(3):516-21.

PMID:
15351582
14.

Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.

Cheng L, Poulos CK, Pan CX, Jones TD, Daggy JK, Eble JN, Koch MO.

J Urol. 2005 Sep;174(3):898-902.

PMID:
16093983
16.

Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.

Carter HB, Sauvageot J, Walsh PC, Epstein JI.

J Urol. 1997 Jun;157(6):2206-9. Review.

19.

Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.

Quinn DI, Henshall SM, Brenner PC, Kooner R, Golovsky D, O'Neill GF, Turner JJ, Delprado W, Grygiel JJ, Sutherland RL, Stricker PD.

Cancer. 2003 Apr 15;97(8):1884-93.

20.
Items per page

Supplemental Content

Write to the Help Desk